Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients
Sara Al‐Khawaga, Essam M. Abdelalim
Stem Cell Research & Therapy (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 69

Showing 26-50 of 69 citing articles:

Mesenchymal Stem Cell-Derived Extracellular Vesicles: Immunomodulatory Effects and Potential Applications in Intervertebral Disc Degeneration
Shaojun Hu, Hongyuan Xing, Jiangnan Zhang, et al.
Stem Cells International (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 16
Immunogenicity of mesenchymal stromal/stem cells
Wenyan Chen, Lu Lv, Na Chen, et al.
Scandinavian Journal of Immunology (2023) Vol. 97, Iss. 6
Open Access | Times Cited: 10
Application of mesenchymal stem cells in regenerative medicine: A new approach in modern medical science
Faezeh Ebrahimi, Farzaneh Pirouzmand, Renzon Daniel Cosme Pecho, et al.
Biotechnology Progress (2023) Vol. 39, Iss. 6
Closed Access | Times Cited: 10
MSC-derived exosomes carrying a cocktail of exogenous interfering RNAs an unprecedented therapy in era of COVID-19 outbreak
Monire Jamalkhah, Yasaman Asaadi, Mohammadreza Azangou‐Khyavy, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 23
COVID-19-Induced Stroke and the Potential of Using Mesenchymal Stem Cells-Derived Extracellular Vesicles in the Regulation of Neuroinflammation
Leyla Norouzi‐Barough, Amir Asgari Khosroshahi, Ali Gorji, et al.
Cellular and Molecular Neurobiology (2022) Vol. 43, Iss. 1, pp. 37-46
Open Access | Times Cited: 15
Human Umbilical Cord Mesenchymal Stem Cells Promote Macrophage PD-L1 Expression and Attenuate Acute Lung Injury in Mice
Chengshu Tu, Zhangfan Wang, Enfei Xiang, et al.
Current Stem Cell Research & Therapy (2022) Vol. 17, Iss. 6, pp. 564-575
Closed Access | Times Cited: 14
Extracellular vesicles: effectors of transfusion-related acute lung injury
Wolfgang M. Kuebler, Nishaka William, Martin Post, et al.
AJP Lung Cellular and Molecular Physiology (2023) Vol. 325, Iss. 3, pp. L327-L341
Closed Access | Times Cited: 8
Mesenchymal Stem Cell-Derived Exosomes and Their Potential Agents in Hematological Diseases
Min Shen, Tong Chen
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 20
Bioengineered tissue and cell therapy products are efficiently cryopreserved with pathogen-inactivated human platelet lysate-based solutions
María Martín-López, Cristina Rosell‐Valle, Blanca Arribas-Arribas, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Immunopathology and Immunosenescence, the Immunological Key Words of Severe COVID-19. Is There a Role for Stem Cell Transplantation?
Mattia Emanuela Ligotti, Fanny Pojero, Giulia Accardi, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 15
Advanced cell therapy with low tissue factor loaded product NestaCell® does not confer thrombogenic risk for critically ill COVID-19 heparin-treated patients
Rodrigo Pinheiro Araldi, Benedito C. Prezoto, Vivian Fonseca Gonzaga, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112920-112920
Open Access | Times Cited: 10
The Role of Extracellular Vesicles in COVID-19 Pathology
Aline Seiko Carvalho Tahyra, Rodrigo T. Calado, Fausto Almeida
Cells (2022) Vol. 11, Iss. 16, pp. 2496-2496
Open Access | Times Cited: 10
Identifying diseases associated with Post-COVID syndrome through an integrated network biology approach
Navami Krishna, K. P. Sijina, G. K. Rajanikant
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 2, pp. 652-671
Closed Access | Times Cited: 6
Mechanistic and Therapeutic Implications of Extracellular Vesicles as a Potential Link Between Covid-19 and Cardiovascular Disease Manifestations
Gianluigi Pironti, Daniel Andersson, Lars H. Lund
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 13
(Epi)transcriptomics in cardiovascular and neurological complications of COVID-19
Amela Jusić, Konstantinos Stellos, Lino Ferreira, et al.
Journal of Molecular and Cellular Cardiology Plus (2022) Vol. 1, pp. 100013-100013
Open Access | Times Cited: 9
Potential roles of mesenchymal stem cells and their exosomes in the treatment of COVID-19
Xiaoyun Cheng, Mao Jiang, Lingzhi Long, et al.
Frontiers in Bioscience-Landmark (2021) Vol. 26, Iss. 10, pp. 948-948
Open Access | Times Cited: 10
Immune response and potential therapeutic strategies for the SARS-CoV-2 associated with the COVID-19 pandemic
Xianghui Li, Yabo Zhang, Libing He, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 5, pp. 1865-1877
Open Access | Times Cited: 7
Non-pharmacological treatments for COVID-19: current status and consensus
Adriano Alves Pereira, Adriano de Oliveira Andrade, Angélica de Andrade Palis, et al.
Research on Biomedical Engineering (2021) Vol. 38, Iss. 1, pp. 193-208
Open Access | Times Cited: 9
Mesenchymal Stem Cells: Potential Therapeutic Prospect of Paracrine Pathways in Neonatal Infection
Jiayu Miao, Zhuxiao Ren, Zhicheng Zhong, et al.
Journal of Interferon & Cytokine Research (2021) Vol. 41, Iss. 10, pp. 365-374
Closed Access | Times Cited: 9
Clinical efficacy analysis of mesenchymal stem cell therapy in patients with COVID-19: A systematic review
Junxia Cao, Jia You, L. Wu, et al.
World Journal of Clinical Cases (2022) Vol. 10, Iss. 27, pp. 9714-9726
Open Access | Times Cited: 6
COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions
Babak Arjmand, Sepideh Alavi-Moghadam, Peyvand Parhizkar Roudsari, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 8
The anti‐inflammatory effects of mesenchymal stem cells attenuate diffuse pulmonary hemorrhage
Yajin Guan, Qianqing Chen, Jiahuan Xu, et al.
Biotechnology Journal (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Exploring extracellular vesicles as mediators of clinical disease and vehicles for viral therapeutics: Insights from the COVID-19 pandemic
Vaughn D. Craddock, Christine Cook, Navneet K. Dhillon
Extracellular Vesicles and Circulating Nucleic Acids (2022) Vol. 3, Iss. 3, pp. 172-88
Open Access | Times Cited: 5
Taming of Covid-19: potential and emerging application of mesenchymal stem cells
Nima Najafi-Ghalehlou, Mehryar Habibi Roudkenar, Habib Zayeni Langerodi, et al.
Cytotechnology (2021) Vol. 73, Iss. 2, pp. 253-298
Open Access | Times Cited: 6
Extracellular Vesicles: The Invisible Heroes and Villains of COVID‐19 Central Neuropathology
Haiqing Chang, Erya Chen, Yi Hu, et al.
Advanced Science (2023) Vol. 11, Iss. 10
Open Access | Times Cited: 2

Scroll to top